Patents by Inventor Kathleen M. Phelan

Kathleen M. Phelan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
    Patent number: 6818772
    Abstract: The present invention relates to the antagonism of the effects of melanin-concentrating hormone (MCH) through the melanin concentrating hormone receptor which is useful for the prevention or treatment of eating disorders, weight gain, obesity, abnormalities in reproduction and sexual behavior, thyroid hormone secretion, diuresis and water/electrolyte homeostasis, sensory processing, memory, sleeping, arousal, anxiety, depression, seizures, neurodegeneration and psychiatric disorders.
    Type: Grant
    Filed: February 21, 2003
    Date of Patent: November 16, 2004
    Assignee: Abbott Laboratories
    Inventors: Philip R. Kym, Kresna Hartandi, Ju Gao, Kathleen M. Phelan, Irini Akritopoulou-Zanze, Christine A. Collins, Anil Vasudevan, Mary K. Verzal
  • Antagonists of melanin concentrating hormone effects on the melanin concetrating hormone receptor
    Publication number: 20030229119
    Abstract: The present invention relates to the antagonism of the effects of melanin-concentrating hormone (MCH) through the melanin concentrating hormone receptor which is useful for the prevention or treatment of eating disorders, weight gain, obesity, abnormalities in reproduction and sexual behavior, thyroid hormone secretion, diuresis and water/electrolyte homeostasis, sensory processing, memory, sleeping, arousal, anxiety, depression, seizures, neurodegeneration and psychiatric disorders.
    Type: Application
    Filed: February 21, 2003
    Publication date: December 11, 2003
    Inventors: Philip R. Kym, Kresna Hartandi, Ju Gao, Kathleen M. Phelan, Irini Akritopoulou-Zanze, Christine A. Collins, Anil Vasudevan, Mary K. Verzal
  • Cyclic and bicyclic diamino histamine-3 receptor antagonists
    Patent number: 6559140
    Abstract: Compounds of formula (I) compounds of formula (II) compounds of formula (III) and compounds of formula (IV) or pharmaceutically acceptable salts thereof are useful as H3 receptor antagonists. Processes to make the compounds and methods of treatment using the compounds are also disclosed.
    Type: Grant
    Filed: March 5, 2001
    Date of Patent: May 6, 2003
    Assignee: Abbott Laboratories
    Inventors: Youssef L. Bennani, Lawrence A. Black, Wesley J. Dwight, Ramin Faghih, Robert G. Gentles, Huaqing Liu, Kathleen M. Phelan, Anil Vasudevan, Henry Q. Zhang
  • Cyclic and bicyclic diamino histamine-3 receptor antagonists
    Publication number: 20010049367
    Abstract: Compounds of formula (I) 1
    Type: Application
    Filed: March 5, 2001
    Publication date: December 6, 2001
    Inventors: Youssef L. Bennani, Lawrence A. Black, Wesley J. Dwight, Ramin Faghih, Robert G. Gentles, Huaqing Liu, Kathleen M. Phelan, Anil Vasudevan, Henry Q. Zhang